Sponsor Dossier
Dr Falk Pharma
Sponsor Dossier for Dr Falk Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: BUDENOFALK
- Brand: JORVEZA
- Brand: SALOFALK
- Brand: URSO
- Brand: URSOFALK
- Device (sponsor): Applicator, <specify>
About
Dr Falk Pharma is an Australian Private Company with ABN 40631091131, registered in New South Wales. The company is Active on the Australian Business Register.
Portfolio
Dr Falk Pharma has five brands on the ARTG, all of which are indexable. All five brands have Product Information on file. Four brands are PBS-listed, four have PBAC outcomes on record, and one has an AusPAR on record. Notable brands include BUDENOFALK, JORVEZA, SALOFALK, URSO, and URSOFALK.
Therapeutic focus
— Gastroenterology: 3 brands — Immunology: 2 brands
PBS footprint
Four brands in the portfolio are PBS-listed, with the portfolio most recently touching the PBS schedule on 1 May 2026.
Regulatory activity
The most recent PBAC outcome for the portfolio is dated 1 March 2023, with four brands holding PBAC outcomes on record. The most recent AusPAR is dated 11 May 2012, with one brand holding an AusPAR on record.